Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer risks in thyroid cancer patients.
Hall P, Holm LE, Lundell G, Bjelkengren G, Larsson LG, Lindberg S, Tennvall J, Wicklund H, Boice JD Jr. Hall P, et al. Among authors: bjelkengren g. Br J Cancer. 1991 Jul;64(1):159-63. doi: 10.1038/bjc.1991.261. Br J Cancer. 1991. PMID: 1854616 Free PMC article.
Leukaemia incidence after iodine-131 exposure.
Hall P, Boice JD Jr, Berg G, Bjelkengren G, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Mattsson A, Tennvall J, et al. Hall P, et al. Among authors: bjelkengren g. Lancet. 1992 Jul 4;340(8810):1-4. doi: 10.1016/0140-6736(92)92421-b. Lancet. 1992. PMID: 1351599
Cancer mortality after iodine-131 therapy for hyperthyroidism.
Hall P, Berg G, Bjelkengren G, Boice JD Jr, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Tennvall J, Wiklund K, et al. Hall P, et al. Among authors: bjelkengren g. Int J Cancer. 1992 Apr 1;50(6):886-90. doi: 10.1002/ijc.2910500611. Int J Cancer. 1992. PMID: 1555888
Cancer risk after iodine-131 therapy for hyperthyroidism.
Holm LE, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, Cederquist E, Ericsson UB, Hallquist A, Larsson LG, et al. Holm LE, et al. Among authors: bjelkengren g. J Natl Cancer Inst. 1991 Aug 7;83(15):1072-7. doi: 10.1093/jnci/83.15.1072. J Natl Cancer Inst. 1991. PMID: 1875414
Cancer risk in population examined with diagnostic doses of 131I.
Holm LE, Wiklund KE, Lundell GE, Bergman NA, Bjelkengren G, Ericsson UB, Cederquist ES, Lidberg ME, Lindberg RS, Wicklund HV, et al. Holm LE, et al. Among authors: bjelkengren g. J Natl Cancer Inst. 1989 Feb 15;81(4):302-6. doi: 10.1093/jnci/81.4.302. J Natl Cancer Inst. 1989. PMID: 2913329
Thyroid cancer after diagnostic doses of iodine-131: a retrospective cohort study.
Holm LE, Wiklund KE, Lundell GE, Bergman NA, Bjelkengren G, Cederquist ES, Ericsson UB, Larsson LG, Lidberg ME, Lindberg RS, et al. Holm LE, et al. Among authors: bjelkengren g. J Natl Cancer Inst. 1988 Sep 21;80(14):1132-8. doi: 10.1093/jnci/80.14.1132. J Natl Cancer Inst. 1988. PMID: 3411626
[Low risk of cancer after treatment of hyperthyroidism with iodine-131].
Holm LE, Hall P, Lundell G, Berg G, Bjelkengren G, Ericsson UB, Tennvall J, Hallquist A, Lidberg M, Wiklund K. Holm LE, et al. Among authors: bjelkengren g. Lakartidningen. 1992 Sep 16;89(38):3043-6. Lakartidningen. 1992. PMID: 1369747 Swedish. No abstract available.
[There is no increased risk of thyroid cancer after diagnostic doses of 131I].
Holm LE, Ericsson UB, Wiklund K, Larsson LG, Lundell G, Lidberg M, Bergman A, Lindberg S, Bjelkengren G, Wicklund H, et al. Holm LE, et al. Among authors: bjelkengren g. Lakartidningen. 1989 Aug 30;86(35):2864-6. Lakartidningen. 1989. PMID: 2796466 Swedish. No abstract available.
Number of patients potentially eligible for proton therapy.
Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson T, Blomquist E, Johansson B, Karlsson M, Zackrisson B. Glimelius B, et al. Among authors: bjelkengren g. Acta Oncol. 2005;44(8):836-49. doi: 10.1080/02841860500361049. Acta Oncol. 2005. PMID: 16332591
22 results